Biosciences
Our researchers in have a rich legacy of collaboration with government agencies and industry partners that improve health outcomes and well-being around the world. SRI Biosciences projects range from high-impact, early-stage research to drug co-development with pharmaceutical and biotech companies.
-
SRI International Awarded Contract Worth Up to $100M from National Institute of Allergy and Infectious Diseases for Radiation/Nuclear Medical Countermeasures
Grant extends SRI’s long history of collaborations with the National Institutes of Health.
-
Developing the next generation of PCR diagnostics for point-of-contact screening
SRI International investigator awarded National Science Foundation grant for development of a revolutionary point of contact diagnostic for infectious diseases The current world-wide COVID-19 pandemic underscores the need for rapid and widespread screening for emerging infectious agents. As emerging infectious diseases can spread rapidly, government agencies have made developing detection technologies a priority. To explore…
-
Nathan Collins talks about the SynFini™ automated chemistry platform (Part 1)
Nathan Collins discusses how the SynFini automated chemistry platform is accelerating drug development and discovery. Learn more about SynFini at: https://www.sri.com/case-studies/synfini. Nathan Collins is the Chief Strategy Officer of SRI Biosciences in Menlo Park, CA. In part one of this episode of The Dish TV they discuss the processes and problems of new drug discovery…
-
Nathan Collins talks about integrating AI with the SynFini™ Platform (Part 2)
Nathan Collins discusses how integrating AI with the SynFini automated chemistry platform is poised to shape the future of drug discovery and development. Learn more about SynFini at: https://www.sri.com/case-studies/synfini Nathan Collins is the Chief Strategy Officer of SRI Biosciences in Menlo Park, CA. In part two of this episode of The Dish TV they discuss…
-
SRI International and Exscientia Enter Collaboration to Accelerate Drug Discovery Through Automation and Artificial Intelligence
Companies will combine SynFini and Centaur Chemist platforms to focus on small-molecule oncology target.
-
Better Sleep Through Wearables?
Modern technology could be the key to solving our sleep issues.
-
Iktos and SRI International Announce Collaboration to Combine Artificial Intelligence and Novel Automated Discovery Platform for Accelerated Development of New Anti-Viral Therapies
Researchers will utilize Iktos’ generative modeling AI technology with SRI’s SynFini synthetic chemistry platform to discover new compounds against multiple viruses, including the coronavirus (COVID-19).
-
SRI Introduces Novel Synthetic Chemistry System at SLAS 2020
SRI Biosciences Chief Strategy Officer Nathan Collins, Ph.D., will present an overview of SynFini, the company’s fully automated, end-to-end synthetic-chemistry system.
-
If better sleep is part of your New Year’s resolution, check out this study from SRI researchers about the usefulness of a fitness watch for sleep tracking
-
Research Shows Fitness Watch Can Accurately Track Sleep Patterns
Results from first study comparing consumer sleep tracker against research-grade tracker over two weeks in home environment published in Journal of Sleep.
-
The brain may actively forget during dream sleep
In this study, scientists looked at neighboring cells that produce melanin concentrating hormone, a molecule known to be involved in the control of both sleep and appetite.